Biochemical Characterization of GPCR–G Protein Complex Formation

2021 ◽  
pp. 37-48
Author(s):  
Filip Pamula ◽  
Ching-Ju Tsai
Keyword(s):  
Complex Formation ◽  
G Protein ◽  
Protein Complex ◽  
Biochemical Characterization ◽  
Protein Complex Formation

scholarly journals Structural Insights into the Process of GPCR-G Protein Complex Formation

Cell ◽  
2019 ◽  
Vol 177 (5) ◽  
pp. 1243-1251.e12 ◽  
Author(s):  
Xiangyu Liu ◽  
Xinyu Xu ◽  
Daniel Hilger ◽  
Philipp Aschauer ◽  
Johanna K.S. Tiemann ◽  
...  
Keyword(s):  
Complex Formation ◽  
G Protein ◽  
Protein Complex ◽  
Protein Complex Formation ◽  
Structural Insights

scholarly journals Molecular Determinants of GPCR-G Protein Complex Formation

2012 ◽  
Vol 102 (3) ◽  
pp. 31a-32a
Author(s):  
Tarjani M. Thaker ◽  
Ali I. Kaya ◽  
Anita M. Preininger ◽  
Heidi E. Hamm ◽  
T.M. Iverson
Keyword(s):  
Complex Formation ◽  
G Protein ◽  
Protein Complex ◽  
Protein Complex Formation ◽  
Molecular Determinants

scholarly journals Pathological AT1R-B2R Protein Aggregation and Preeclampsia

Cells ◽  
2021 ◽  
Vol 10 (10) ◽  
pp. 2609
Author(s):  
Ursula Quitterer ◽  
Said AbdAlla
Keyword(s):  
Risk Factors ◽  
Complex Formation ◽  
Protein Aggregation ◽  
G Protein ◽  
Protein Complex ◽  
G Protein Coupled Receptors ◽  
Protein Complex Formation ◽  
The Impact ◽  
G Protein Coupled ◽  
Gpcr Protein

Preeclampsia is one of the most frequent and severe complications of pregnancy. Symptoms of preeclampsia usually occur after 20 weeks of pregnancy and include hypertension and kidney dysfunction with proteinuria. Up to now, delivery of the infant has been the most effective and life-saving treatment to alleviate symptoms of preeclampsia because a causative treatment does not exist, which could prolong a pregnancy complicated with preeclampsia. Preeclampsia is a complex medical condition, which is attributed to a variety of different risk factors and causes. Risk factors account for insufficient placentation and impaired vasculogenesis and finally culminate in this life-threatening condition of pregnancy. Despite progress, many pathomechanisms and causes of preeclampsia are still incompletely understood. In recent years, it was found that excessive protein complex formation between G-protein-coupled receptors is a common sign of preeclampsia. Specifically, the aberrant heteromerization of two vasoactive G-protein-coupled receptors (GPCRs), the angiotensin II AT1 receptor and the bradykinin B2 receptor, is a causative factor of preeclampsia symptoms. Based on this knowledge, inhibition of abnormal GPCR protein complex formation is an experimental treatment approach of preeclampsia. This review summarizes the impact of pathological GPCR protein aggregation on symptoms of preeclampsia and delineates potential new therapeutic targets.

Characterization of CRISP2 in ejaculated boar sperm and its involvement in oligomerization protein complex formation

2020 ◽  
Vol 220 ◽  
pp. 106416
Author(s):  
Min Zhang ◽  
R. Zenezini-Chiozzi ◽  
Dora V. Kaloyanova ◽  
J. Bernd Helms ◽  
Bart M. Gadella
Keyword(s):  
Complex Formation ◽  
Protein Complex ◽  
Protein Complex Formation ◽  
Boar Sperm

scholarly journals S  (+)-Ketamine Suppresses Desensitization of γ-Aminobutyric Acid Type B Receptor-mediated Signaling by Inhibition of the Interaction of γ-Aminobutyric Acid Type B Receptors with G Protein–coupled Receptor Kinase 4 or 5

2011 ◽  
Vol 114 (2) ◽  
pp. 401-411 ◽  
Author(s):  
Yuko Ando ◽  
Minoru Hojo ◽  
Masato Kanaide ◽  
Masafumi Takada ◽  
Yuka Sudo ◽  
...  
Keyword(s):  
Complex Formation ◽  
G Protein ◽  
Protein Complex ◽  
Protein Complexes ◽  
Aminobutyric Acid ◽  
K Channel ◽  
Type B ◽  
Protein Complex Formation ◽  
Acid Type ◽  
G Protein Coupled

Background Intrathecal baclofen therapy is an established treatment for severe spasticity. However, long-term management occasionally results in the development of tolerance. One of the mechanisms of tolerance is desensitization of γ-aminobutyric acid type B receptor (GABABR) because of the complex formation of the GABAB2 subunit (GB2R) and G protein-coupled receptor kinase (GRK) 4 or 5. The current study focused on S(+)-ketamine, which reduces the development of morphine tolerance. This study was designed to investigate whether S(+)-ketamine affects the GABABR desensitization processes by baclofen. Methods The G protein-activated inwardly rectifying K channel currents induced by baclofen were recorded using Xenopus oocytes coexpressing G protein-activated inwardly rectifying K channel 1/2, GABAB1a receptor subunit, GB2R, and GRK. Translocation of GRKs 4 and 5 and protein complex formation of GB2R with GRKs were analyzed by confocal microscopy and fluorescence resonance energy transfer analysis in baby hamster kidney cells coexpressing GABAB1a receptor subunit, fluorescent protein-tagged GB2R, and GRKs. The formation of protein complexes of GB2R with GRKs was also determined by coimmunoprecipitation and Western blot analysis. Results Desensitization of GABABR-mediated signaling was suppressed by S(+)-ketamine in a concentration-dependent manner in the electrophysiologic assay. Confocal microscopy revealed that S(+)-ketamine inhibited translocation of GRKs 4 and 5 to the plasma membranes and protein complex formation of GB2R with the GRKs. Western blot analysis also showed that S(+)-ketamine inhibited the protein complex formation of GB2R with the GRKs. Conclusion S(+)-Ketamine suppressed the desensitization of GABABR-mediated signaling at least in part through inhibition of formation of protein complexes of GB2R with GRK 4 or 5.

Sign in / Sign up

Export Citation Format

Share Document